Skip to main content
TipRanks
Go Ultimate75% OFF

Glenmark Life Sciences Limited (ALIVUS) Financial Statements

6 Followers

Glenmark Life Sciences Limited Financial Overview

Glenmark Life Sciences Limited's market cap is currently ₹176.35B. The company's EPS TTM is ₹20.67; its P/E ratio is 26.34; and it has a dividend yield of 0.35%. Glenmark Life Sciences Limited has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Mar 25Mar 24Mar 22Mar 21Mar 20
Income Statement
Total Revenue₹ 25.52B₹ 22.83B₹ 21.61B₹ 18.85B₹ 15.37B
Gross Profit₹ 11.37B₹ 12.43B₹ 11.47B₹ 9.80B₹ 8.47B
Operating Income₹ 7.22B₹ 8.98B₹ 6.01B₹ 5.62B₹ 4.44B
EBITDA₹ 8.32B₹ 6.86B₹ 6.71B₹ 5.92B₹ 4.84B
Net Income₹ 5.64B₹ 4.71B₹ 4.67B₹ 3.52B₹ 3.13B
Balance Sheet
Cash & Short-Term Investments₹ 7.83B₹ 3.01B₹ 3.80B₹ 1.40B₹ 307.68M
Total Assets₹ 39.83B₹ 28.50B₹ 27.02B₹ 19.97B₹ 17.26B
Total Debt₹ 567.71M₹ 171.48M₹ 193.57M₹ 9.33B₹ 210.00K
Net Debt₹ 546.39M₹ -2.84B₹ -2.64B₹ 8.17B₹ -99.77M
Total Liabilities₹ 6.51B₹ 5.18B₹ 5.64B₹ 12.44B₹ 13.24B
Stockholders' Equity₹ 33.32B₹ 23.32B₹ 21.38B₹ 7.53B₹ 4.02B
Cash Flow
Free Cash Flow₹ 2.59B₹ 2.85B₹ 1.43B₹ 3.20B₹ 1.44B
Operating Cash Flow₹ 5.66B₹ 4.14B₹ 3.13B₹ 3.88B₹ 1.95B
Investing Cash Flow₹ -5.71B₹ -1.16B₹ -1.54B₹ -687.34M₹ -505.18M
Financing Cash Flow₹ -641.34M₹ -2.79B₹ -3.88B₹ -2.14B₹ -1.37B

Currency in INR

Glenmark Life Sciences Limited Earnings and Revenue History

-15B015B30B-200 %-100 %0 %100 %EarningsProfit Margin201720192021202220242025RevenueEarningsProfit Margin

Glenmark Life Sciences Limited Liabilities to Assets

015B30B45B0 %800 %1600 %2400 %LiabilitiesLiabilities to Assets201720192021202220242025AssetsLiabilitiesLiabilities to Assets

Glenmark Life Sciences Limited Cash Flow

-7.5B-5B-2.5B02.5B5B7.5B201720192021202220242025OperatingInvestingFinancing

Glenmark Life Sciences Limited Forecast EPS vs Actual EPS

81012141618Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27EPS EstimateBeatMiss